A new study shows, as has been seen for cardiovascular events, a significant relationship between markers of abdominal obesity and fat mass and the risk for stroke or transient ischemic attack. Medscape Medical News
With an ever-expanding armamentarium, does the choice of agents influence the ability to safely reach our goals in the management of type 2 diabetes? Medscape Dermatology
In this Journal Scan: comparing the efficacy of exenatide and insulin, reviewing the safety and efficacy of sitagliptin monotherapy, and determining the cost-effectiveness of exenatide. Medscape Dermatology
In a 2-year safety study, inhaled human insulin treatment caused small changes in forced expiratory volume in 1 second in patients with type 2 diabetes. Medscape Medical News
Excess body weight increases the risk of recurrent venous thromboembolism (VTE) after a first unprovoked venous thromboembolism, according to a report in the August 11/25 Archives of Internal Medicine. Reuters Health Information
Combination treatment with metformin and the incretin mimetic exenatide improves reproductive function and normalizes hormonal and metabolic derangements in overweight women with polycystic ovarian syndrome (PCOS), results of a small pilot study suggest. Reuters Health Information
In a study of Chinese patients with type 2 diabetes, very low levels of LDL-cholesterol, as well as very high levels, were associated with increased risks of mortality and cancer, investigators report in the August 26th issue of the Canadian Medical Association Journal. Reuters Health Information
A study shows that bone mineral density decreases in young women with type 1 diabetes and may affect the risk for future postmenopausal osteoporotic fractures. Medscape Medical News